h4-12

Sch412348 is a potent competitive the human adenosine A2A receptor antagonist with Ki of 0.6 nM and has >1000-fold selectivity over all other adenosine receptors.

VH4127 is a cyclic peptide designed to target low-density lipoprotein receptors (LDLR) with a KD of 18 nM for hLDLR. Incorporating non-natural amino acid residues, VH4127 binds specifically to epidermal growth factor (EGF) LDLR homologous domains in both rodents and humans.

VH4127 TFA is a cyclic peptide with a KD of 18 nM for human low-density lipoprotein receptor (hLDLR). It can specifically bind to epidermal growth factor (EGF) LDLR homologous domains in both rodents and humans.

H-PEG6-VH4127-NH2 is a derivative of VH4127, designed to facilitate further conjugation with proteins.

KMI169 is a potent and selective bisubstrate inhibitor targeting KMT9's SAM and substrate binding pockets. KMT9 monomethylates histone H4 at lysine 12 and regulates the proliferation of prostate cancer cells. KMI169 can be utilized for research in prostate cancer.

Maximin H4, an antimicrobial peptide originating from the skin secretions of the Chinese red belly toad (Bombina maxima), exhibits inhibitory activity against a spectrum of microorganisms, including Escherichia coli (ATCC25922), Staphylococcus aureus (ATCC2592), Bacillus pyocyaneus (CMCCB1010), and Candida albicans (ATCC2002), with respective minimum inhibitory concentration (MIC) values of 12, 6, 12, and 6 μg/ml [1].

Ustusol H4 is a natural product for research related to life sciences. The catalog number is TN5359 and the CAS number is 2193060-25-0.